Janus Henderson Group PLC Amneal Pharmaceuticals, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
183Shares Held
141MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$202 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$135 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$114 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$104 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$99.2 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.4B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...